共 25 条
[1]
Pirraglia P.A., Stafford R.S., Singer D.E., Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care. Prim Care Companion, J Clin Psychiatry, 5, pp. 153-157, (2003)
[2]
Kallen B., Fluoxetine use in early pregnancy, Birth Defects Res B Dev Reprod Toxicol, 71, pp. 395-396, (2004)
[3]
Chambers C.D., Johnson K.A., Dick L.M., Felix R.J., Jones K.L., Birth outcomes in pregnant women taking fluoxetine, N Engl J Med, 335, pp. 1010-1015, (1996)
[4]
Moses-Kolko E.L., Bogen D., Perel J., Et al., Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications, JAMA, 293, pp. 2372-2383, (2005)
[5]
Chambers C.D., Hernandez-Diaz S., Van Marter L.J., Et al., Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn, N Engl J Med, 354, pp. 579-587, (2006)
[6]
Bennett H.A., Einarson A., Taddio A., Koren G., Einarson T.R., Prevalence of depression during pregnancy: systematic review, Obstet Gynecol, 103, pp. 698-709, (2004)
[7]
Mills J.L., Depressing observations on the use of selective serotonin-reuptake inhibitors during pregnancy, N Engl J Med, 354, pp. 636-638, (2006)
[8]
Ray W.A., Griffin M.R., Use of Medicaid data for pharmacoepidemiology, Am J Epidemiol, 129, pp. 837-849, (1989)
[9]
West S.L., Savitz D.A., Koch G., Strom B.L., Guess H.A., Hartzema A., Recall accuracy for prescription medications: self-report compared with database information, Am J Epidemiol, 142, pp. 1103-1112, (1995)
[10]
Johnson R.E., Vollmer W.M., Comparing sources of drug data about the elderly, J Am Geriatr Soc, 39, pp. 1079-1084, (1991)